Japan Animal Referral Medical Center sees strong growth in first half 2025

JARMeC reported a substantial increase in net sales for the six months ended September 30, 2025, reaching JPY 3,033 million, an 18.1% rise year-on-year. Operating profit surged by 68.4% to JPY 591 million, while ordinary profit grew by 67.5% to JPY 589 million. Profit attributable to owners of parent also saw a strong increase of 70.2% to JPY 413 million, with earnings per share at JPY 159.88.

The company's financial position strengthened, with total assets increasing to JPY 9,034 million as of September 30, 2025, from JPY 8,753 million as of March 31, 2025. Net assets also rose to JPY 4,461 million, improving the equity ratio to 49.4% from 47.4% at the end of the previous fiscal year.

Looking ahead, JARMeC forecasts continued growth for the full year ending March 31, 2026, projecting net sales of JPY 6,100 million (a 15.6% increase year-on-year) and ordinary profit of JPY 1,030 million (a 43.0% increase). Earnings per share are expected to reach JPY 282.42, and the company plans an annual dividend of JPY 40.00 per share for the fiscal year 2026.